Skip to main content
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.71
+0.22 (0.94%)
At close: Apr 28, 2026, 4:00 PM EDT
24.18
+0.47 (1.98%)
After-hours: Apr 28, 2026, 6:32 PM EDT

Immunome Revenue

In the year 2025, Immunome had annual revenue of $6.94M, down -23.23%.

Revenue (ttm)
$6.94M
Revenue Growth
-23.23%
P/S Ratio
386.46
Revenue / Employee
$39,215
Employees
177
Market Cap
2.68B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.94M-2.10M-23.23%
Dec 31, 20249.04M-4.98M-35.50%
Dec 31, 202314.02M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ADMA Biologics 510.17M
Zai Lab 460.16M
Tarsus Pharmaceuticals 451.36M
IDEAYA Biosciences 218.71M
Soleno Therapeutics 190.41M
Nektar Therapeutics 55.23M
Celldex Therapeutics 1.55M
Revenue Rankings

IMNM News

More News